Literature DB >> 34467502

ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence.

F Crafa1, S Vanella2, E Coppola Bottazzi2, A Noviello2, A Miro2, T Palma2, I Apicella2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34467502     DOI： 10.1245/s10434-021-10696-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Contrast-enhanced ultrasonography during liver surgery.

Authors:  G Torzilli; D Del Fabbro; N Olivari; F Calliada; M Montorsi; M Makuuchi
Journal:  Br J Surg       Date:  2004-09       Impact factor: 6.939

2.  Extrahepatic division of the right hepatic vein in hepatectomy.

Authors:  M Makuuchi; J Yamamoto; T Takayama; T Kosuge; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Hepatogastroenterology       Date:  1991-04

Review 3.  Parenchyma-sparing liver resections.

Authors:  Guido Torzilli; Lucas McCormack; Timothy Pawlik
Journal:  Int J Surg       Date:  2020-04-23       Impact factor: 6.071

4.  ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence.

Authors:  F Crafa; S Vanella; E Coppola Bottazzi; A Noviello; A Miro; T Palma; I Apicella
Journal:  Ann Surg Oncol       Date:  2021-09-01       Impact factor: 5.344

5.  The Liver Tunnel: Intention-to-treat Validation of a New Type of Hepatectomy.

Authors:  Guido Torzilli; Fabio Procopio; Luca Viganò; Guido Costa; Andrea Fontana; Matteo Cimino; Matteo Donadon; Daniele Del Fabbro
Journal:  Ann Surg       Date:  2019-02       Impact factor: 12.969
  5 in total
  1 in total

1.  ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence.

Authors:  F Crafa; S Vanella; E Coppola Bottazzi; A Noviello; A Miro; T Palma; I Apicella
Journal:  Ann Surg Oncol       Date:  2021-09-01       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.